OTC - ACTIVE INGREDIENT SECTION
octinoxate, octisalate, ensulizole
octinoxate, octisalate, ensulizole
water, glycerin, dipropylene glycol, etc.
helps prevent sunburn
1. If the following symptoms occur after product use, stop using the product immediately and consult a dermatologist (continuous use can exacerbate the symptoms).
1) Occurrence of red spots, swelling, itchiness, and other irritation
2) If the symptoms above occur after the application area is exposed to direct sunlight
2. Do not use on open wounds, eczema, and other irritations
3. Precaution for Storage and Handling
1) Close the lid after use
2) Keep out of reach of infants and children
3) Do not to store in a place with high/low temperature and exposed to direct sunlight
4. Use as avoiding eye areas.
Keep out of reach of children.
Apply liberally 15 minutes before sun exposure
external use only
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0861232000448 | GTIN-13: 0861232000448 EAN-13: 0861232000448 GTIN-12: 861232000448 UPC-A: 861232000448 GTIN storage (14 digits): 00861232000448 | label.jpg |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69133-050-01 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-0e71-a910-e053-dadaa90a0b85 | 734b1a67-ee62-1f8a-e053-2a91aa0a994c |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69133-050-01 | DR NIKKO SHEER SUNSCREEN | 50 mL in 1 TUBE | CREAM | 50 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69133-050 | 69133-050-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| OCTINOXATE | 4Y5P7MUD51 | ACTIB |
| ENSULIZOLE | 9YQ9DI1W42 | ACTIB |
| OCTISALATE | 4X49Y0596W | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 734b1adf-ad78-45cb-e053-2a91aa0a8f0c | 734b1a67-ee62-1f8a-e053-2a91aa0a994c | 2018-08-13 | Warnings | 734b1adf-ad78-45cb-e053-2a91aa0a8f0c 734b1a67-ee62-1f8a-e053-2a91aa0a994c |
Adverse event summaries are temporarily unavailable. Other product information remains available.